Literature DB >> 4096989

[Clinical study of amiodarone in cardiac rhythmic disorders].

J Van Schepdael, H Solvay.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4096989

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0032-7867            Impact factor:   1.228


× No keyword cloud information.
  12 in total

Review 1.  Recent advances in understanding the pharmacology of amiodarone.

Authors:  S Nattel; M Talajic
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

2.  Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment.

Authors:  S B Olsson; L Brorson; E Varnauskas
Journal:  Br Heart J       Date:  1973-12

3.  Amiodarone in the treatment of refractory supraventricular and ventricular arrhythmias.

Authors:  P J Wheeler; R Puritz; D V Ingram; D A Chamberlain
Journal:  Postgrad Med J       Date:  1979-01       Impact factor: 2.401

Review 4.  Is there an ideal antiarrhythmic drug? A review--with particular reference to class I antiarrhythmic agents.

Authors:  K A Muhiddin; P Turner
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

5.  Does amiodarone affect heart rate by inhibiting the intracellular generation of triiodothyronine from thyroxine?

Authors:  M Lindenmeyer; S Spörri; M Stäubli; A Studer; H Studer
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

6.  Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity.

Authors:  M Stäubli; J Bircher; R L Galeazzi; H Remund; H Studer
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias.

Authors:  D E Ward; A J Camm; R A Spurrell
Journal:  Br Heart J       Date:  1980-07

Review 8.  Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia.

Authors:  Hugo Van Herendael; Paul Dorian
Journal:  Vasc Health Risk Manag       Date:  2010-08-09

9.  Mass spectrometric identification of amiodarone N-monodesethyl metabolite and application of an HPLC method to a pharmacokinetic study.

Authors:  D Marchiset; C Aubert; Y C Sumirtapura; A Egre; J P Cano
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Apr-Jun       Impact factor: 2.441

10.  Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.

Authors:  E Rowland; D M Krikler
Journal:  Br Heart J       Date:  1980-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.